Nyxoah S.A.
NASDAQ:NYXHMedical - Instruments & Supplies
+$0.02 today
- Market cap
- $87.89M
- Beta
- 0.89
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$1.99
Volume 0.17M
Average 0.22M
NYXH Total Debt
Short-term and long-term borrowings combined.
Nyxoah S.A.NASDAQ: NYXH
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt rises 64.0% from a year ago
Total debt stood at €36.22M at the end of Q1 FY2026, up 64.0% from a year earlier and down 10.5% from the prior quarter. Over 3 fiscal years it compounded at +52.4% a year.
Context
- Total debt amounted to 37.0% of total assets at the end of Q1 FY2026, up 20.7 pp from a year earlier.
- Total debt increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total debt keeps rising in the next quarterly balance sheet after a +64.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
EUR · from the balance sheet
- Latest · FY2025
- 42.06M EUR
- Year-over-year change
- +85.7%
- 4-year CAGR
- +37.8%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 42.06M | +85.7% |
| FY2024 | 2024-12-31 | 22.65M | +78.3% |
| FY2023 | 2023-12-31 | 12.7M | +6.9% |
| FY2022 | 2022-12-31 | 11.88M | +1.8% |
| FY2021 | 2021-12-31 | 11.68M | — |
Total Debt vs competitors
How NYXH compares with its peers on the latest reported figures
- Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +64.0% is the 3rd highest of 10, against a peer median of -12.5%.
- Total debt amounts to 37.0% of total assets for NYXH, versus a peer median of 3.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $85.39M USD | +3.5% | +31.5% | 68.1% | |
| Mar 2026 | $40.47M USD | +184.9% | +1.7% | 10.7% | |
| Mar 2026 | €36.22M EUR | +64.0% | +52.4% | 37.0% | |
| Mar 2026 | $19.67M USD | -12.5% | -7.6% | 6.7% | |
| Mar 2026 | $8.63M USD | +864.9% | -12.5% | 3.6% | |
| Mar 2026 | $3.37M USD | -9.8% | -10.8% | 11.8% | |
| Mar 2026 | $3.06M USD | -27.7% | -19.3% | 1.6% | |
| Mar 2026 | $2.62M USD | -31.4% | +45.9% | 0.6% | |
| Mar 2026 | $457K USD | -91.1% | -30.8% | 0.3% | |
| Mar 2026 | $210K USD | -21.9% | -12.9% | 0.2% | |
| Peer median (excluding NYXH) | — | -12.5% | -10.8% | 3.6% | |
Competitors are the stored peer set for NYXH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 135.51M | 17.89M | 21.61M | 34.19M | 29.99M |
| Short-term Investments | 0 | 76.97M | 36.14M | 51.37M | 17.99M |
| Net Receivables | 2.51M | 2.23M | 5.63M | 6.16M | 7.72M |
| Inventory | 346K | 882K | 3.32M | 4.72M | 4.66M |
| Other Current Assets | 3.98M | 828K | 1.66M | 918K | 827.69K |
| Total Current Assets | 140.06M | 100.26M | 68.35M | 98.08M | 61.19M |
| Property, Plant & Equipment (Net) | 5.24M | 5.62M | 7.98M | 8.25M | 5.34M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 25.32M | 39.97M | 46.61M | 50.38M | 50.09M |
| Long-term Investments | 164K | 173K | 0 | 0 | 1.72M |
| Tax Assets | 46K | 47K | 56K | 76K | 86.97K |
| Other Non-current Assets | 0 | 0 | 1.17M | 1.62M | 0 |
| Total Non-current Assets | 30.77M | 45.81M | 55.81M | 60.32M | 57.24M |
| Total Assets | 170.83M | 146.07M | 124.16M | 158.41M | 118.43M |
| Account Payables | 2.39M | 1.87M | 4.1M | 3.75M | 13.72M |
| Short-term Debt | 554K | 389K | 364K | 248K | 23.76M |
| Tax Payables | 2.81M | 3.65M | 1.99M | 4.32M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 117K | 893.66K |
| Other Current Liabilities | 1.15M | 621K | 1.08M | 2.36M | 6.63M |
| Total Current Liabilities | 11.57M | 14.91M | 14.44M | 21.53M | 48.94M |
| Long-term Debt | 7.8M | 8.19M | 8.37M | 18.73M | 17.66M |
| Deferred Tax Liabilities | 5K | 0 | 9K | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 680.74K |
| Other Non-current Liabilities | 92K | 59K | 194K | 2.34M | 1.4M |
| Total Non-current Liabilities | 10.64M | 10.83M | 11.69M | 23.62M | 20.38M |
| Total Liabilities | 22.21M | 25.75M | 26.14M | 45.15M | 69.34M |
| Common Stock | 4.43M | 4.44M | 4.93M | 6.43M | 6.5M |
| Retained Earnings | (87.17M) | (118.21M) | (160.83M) | (217.74M) | (305.91M) |
| Accumulated OCI | 202K | 176K | 137K | 10.21M | 13.51M |
| Other Stockholders Equity | 3.13M | 5.65M | 7.66M | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 148.62M | 120.32M | 98.02M | 113.25M | 49.11M |
| Total Debt | 11.68M | 11.88M | 12.7M | 22.65M | 42.06M |
| Net Debt | (123.83M) | (6.01M) | (8.91M) | (11.53M) | 12.07M |
Nyxoah S.A.
NASDAQ:NYXH
Intrinsic Alpha fair value
Locked
Current Price
$0.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.